Skip to content

OCRA Financial Stewardship

Financial Stewardship

Preserving The Public Trust

Transparency, Accountability, Stewardship

When you donate to OCRA, you can be sure your money is handled responsibly. By ensuring rigorous accountability, financial transparency, and meticulous stewardship of our donors’ funds, OCRA has earned the highest possible rating from Charity Navigator and a Gold rating from Guidestar. We also meet the stringent Standards for Charity Accountability set forth by the Better Business Bureau’s Wise Giving Alliance.

 

Please explore this page to view our financial statements and policies.

Financial Statements

Ovarian Cancer Research Alliance is a 501(c) 3 non profit organization. Our financial documents are public and available for viewing below.

Financial Statements from Ovarian Cancer Research Alliance:

Financial Statements from the former Ovarian Cancer Research Fund:

Financial Statements from the former Ovarian Cancer National Alliance:

Policies

A 501(c)(3) organization, Ovarian Cancer Research Alliance receives funding from individual donors, foundations, corporations, and cause-marketing initiatives. Individual solicitations, direct mail, fundraising events, grant proposals, sponsorships, product sales, and special projects secure these funds.

Our mission is to remain objective in providing information to the ovarian cancer community; we do not endorse any particular treatment, therapy, clinical trial or product.

Ovarian Cancer Research Alliance is committed to:

  • Ensuring that fundraising complies with all applicable federal and state regulations, including appropriate registrations, annual filings, and audits to comply with the Internal Revenue Code;
  • Providing the public with access to its most recent financial reports and filings;
  • Maintaining the confidentiality of donors’ information and ensuring any disclosures comply with all applicable laws;
  • Accepting contributions from sources such as individuals, foundations, and for-profit institutions while ensuring that the positions of Ovarian Cancer Research Alliance on policy issues are never unduly or improperly influenced by contributors.

Conflict of Interest Statement — Industry Partners

  • Corporate partners including industry do not shape OCRA’s agenda, research, or advocacy.
  • In 2023, industry partners represented 8% of OCRA’s overall revenue.
  • If an industry partner sponsors an OCRA program, grant, or educational materials, it is publicly acknowledged and the supporting company has no editorial or strategic input.
  • Any reference to a specific commercial product or service does not constitute or imply an endorsement by OCRA of the product or service or its producer or provider. The views and opinions expressed in any referenced document or on any referenced website do not necessarily reflect those of OCRA.
Read our conflict of interest policy

Related Topics

OCRA Board Member Laura Shawver, PhD, Named to Fierce 50 of 2025

OCRA Board Member Laura Shawver, PhD, Named to Fierce 50 of 2025

Ovarian Cancer Research Alliance (OCRA) congratulates board member Laura Shawver, PhD, on her selection to the Fierce 50 of 2025, a leading industry award from Fierce Life Sciences recognizing individuals and organizations advancing what’s possible in health, science and patient care. Dr. Shawver was selected for her long-standing leadership in oncology research and drug development, … Continued

Read more

Make a Difference with OCRA on GivingTuesday

Make a Difference with OCRA on GivingTuesday

On GivingTuesday, YOU Can Help Shape the Future of Ovarian and Gynecologic Cancer Care Ovarian Cancer Research Alliance (OCRA) is the world’s largest organization combating ovarian and all gynecologic cancers through groundbreaking research, impactful advocacy, and unparalleled patient support while forging new paths in prevention, education, and awareness. We are deeply grateful to our community, … Continued

Read more

Ovarian Cancer Research Alliance Launches Center for Public Policy to Strengthen National Voice for Ovarian and Gynecologic Cancers

Ovarian Cancer Research Alliance Launches Center for Public Policy to Strengthen National Voice for Ovarian and Gynecologic Cancers

New policy hub builds on record of helping to secure billions in federal funding and training thousands of advocates, with expanded priorities and an interactive policy map New York, NY – [November 20, 2025] — Ovarian Cancer Research Alliance (OCRA) today announced the launch of its Center for Public Policy, a dedicated hub that reflects expanded policy … Continued

Read more

Stay Informed

Get email updates about research news, action alerts, and ways to join the fight.

We care about your data. Read our privacy policy.